A global biotech company specialising in Immunology and Inflammation was approaching a criti...
A global biotech company specialising in Immunology and Inflammation was approaching a criti...
From pipeline to patients: oncology launches to watchFiercePharma’s recent report on t...
January’s JP Morgan Healthcare Conference set the tone for the year ahead, and whi...
In this instance, we were working with a US biotech company that had grown from 10 to 40 emp...
As 2025 draws to a close, it is evident that the industry has not pursued radical transforma...
Antibody-drug conjugates have arisen as a groundbreaking class of targeted cancer therapies,...
The pharmaceutical and healthcare industries are experiencing a transformation driven by the...
We delivered market insights and a VP Finance shortlist, supporting a Swiss oncology biotech...